<DOC>
	<DOCNO>NCT01789970</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy hydrocodone bitartrate extended-release tablet dose 30 90 mg every 12 hour compare placebo alleviate moderate severe pain patient chronic low back pain . Patients may opioid-naïve opioid-experienced .</brief_summary>
	<brief_title>Efficacy Safety Hydrocodone Bitartrate Extended-Release Tablets Moderate Severe Chronic Low Back Pain</brief_title>
	<detailed_description>The study consist screening period approximately 7 14 day , open label titration period 6 week , double blind treatment period 12 week . The objective open label titration period find successful dose hydrocodone extend release ( ER ) tablet produce stable pain relief without unacceptable adverse event ( AEs ) . Stable pain relief define average pain intensity ( API ) score previous 24 hour 4 less bad pain intensity ( WPI ) score 6 less 11-point numerical rating scale ( NRS-11 ) ( 0=no pain 10=worst pain imaginable ) either 4 consecutive day 4 7 consecutive day , dose study drug maintain 7 day . Scores WPI API record daily individual patient electronic diary . Patients return study center prior dose adjustment . The start dose hydrocodone ER tablet depend whether subject opioid-naïve opioid-experienced . Opioid-naïve participant start 15-mg dose hydrocodone ER tablets every 12 hour . For opioid-experienced participant , start dose hydrocodone ER tablet approximately equivalent 50 % dose opioid analgesic receive screening administer every 12 hour . Investigators switch participant previous opioid therapy hydrocodone ER tablets basis predefined dose equivalent . Participants meet criterion stabilize dose randomly assign 12 week , double-blind , placebo control treatment period final day open label titration period ( baseline visit ) . Participants begin treatment double blind study drug effective dose hydrocodone ER tablets achieve titration period match placebo . Rescue medication permit addition study drug double blind treatment period . Participants participate study compliance protocol complete 12 week double-blind treatment study drug , consider complete study could eligible enroll 6-month open-label study ( study C32337/3104 , NCT01922739 ) .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<criteria>The patient moderate severe chronic low back pain least 3 month duration screening . The patient able speak English willing provide write informed consent , include write opioid agreement , participate study . The patient willing able successfully selfadminister study drug , comply study restriction , complete electronic diary , return study center schedule study visit , specify protocol . The patient 18 80 year age time screen . Women childbearing potential ( surgically sterile 2 year postmenopausal ) must use medically accept method contraception , agree continue use method duration study 30 day participation study , negative pregnancy test screening . Acceptable method contraception include barrier method spermicide , intrauterine device ( IUD ) , steroidal contraceptive ( oral , transdermal , implanted , inject ) conjunction barrier method . NOTE : A woman consider surgically sterile tubal ligation , hysterectomy , bilateral salpingooophorectomy bilateral oophorectomy , hysterectomy bilateral salpingooophorectomy . Other criterion apply . The patient take total 135 mg/day oxycodone , equivalent , 14 day screen . The patient 's primary painful condition study relate source chronic pain low back pain . The patient radicular ( nerve compression ) pain another type purely neuropathic pain . The patient know suspected hypersensitivity , allergy , contraindication ingredient study drug . The patient recent history ( within 5 year ) current evidence alcohol substance abuse , exception nicotine . The patient medical psychiatric disease , opinion investigator , would compromise collect data . Other criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>chronic low back pain</keyword>
	<keyword>hydrocodone bitartrate</keyword>
	<keyword>opioids</keyword>
</DOC>